Literature DB >> 16140767

The human herpesvirus 6 G protein-coupled receptor homolog U51 positively regulates virus replication and enhances cell-cell fusion in vitro.

Zhu Zhen1, Birgit Bradel-Tretheway, Sarah Sumagin, Jean M Bidlack, Stephen Dewhurst.   

Abstract

Human herpesvirus 6 (HHV-6) is a ubiquitous T-lymphotropic betaherpesvirus that encodes two G protein-coupled receptor homologs, U12 and U51. HHV-6A U51 has been reported to bind to CC chemokines including RANTES, but the biological function of U51 remains uncertain. In this report, we stably expressed short interfering RNAs (siRNAs) specific for U51 in human T cells and then infected these cells with HHV-6. Viral DNA replication was reduced 50-fold by the U51 siRNA, and virally induced cytopathic effects were also inhibited. In contrast, viral replication and syncytium formation were unaltered in cells that expressed a scrambled derivative of the siRNA or an irrelevant siRNA and were restored to normal when a human codon-optimized derivative of U51 was introduced into cells containing the U51 siRNA. To examine the mechanism whereby U51 might contribute to viral replication, we explored the signaling characteristics of U51. None of the chemokines and opioids tested was able to induce G protein coupling by U51, and no evidence for opioid ligand binding by U51 was obtained. The effect of U51 on cell-cell fusion was also evaluated; these studies showed that U51 enhanced cell fusion mediated by the G protein of vesicular stomatitis virus. However, a U51-specific antiserum had no virus-neutralizing activity, suggesting that U51 may not be involved in the initial interaction between the virus particle and host cell. Overall, these studies suggest that HHV-6 U51 is a positive regulator of virus replication in vitro, perhaps because it may promote membrane fusion and facilitates cell-cell spread of this highly cell-associated virus.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16140767      PMCID: PMC1212626          DOI: 10.1128/JVI.79.18.11914-11924.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  59 in total

1.  The VP16 transcription activation domain is functional when targeted to a promoter-proximal RNA sequence.

Authors:  L S Tiley; S J Madore; M H Malim; B R Cullen
Journal:  Genes Dev       Date:  1992-11       Impact factor: 11.361

2.  A population-based study of primary human herpesvirus 6 infection.

Authors:  Danielle M Zerr; Amalia S Meier; Stacy S Selke; Lisa M Frenkel; Meei-Li Huang; Anna Wald; Margaret P Rhoads; Long Nguy; Rena Bornemann; Rhoda Ashley Morrow; Lawrence Corey
Journal:  N Engl J Med       Date:  2005-02-24       Impact factor: 91.245

3.  Human herpesvirus 6 infection inhibits specific lymphocyte proliferation responses and is related to lymphocytopenia after allogeneic stem cell transplantation.

Authors:  F Z Wang; A Linde; H Dahl; P Ljungman
Journal:  Bone Marrow Transplant       Date:  1999-12       Impact factor: 5.483

4.  The human cytomegalovirus UL78 gene is highly conserved among clinical isolates, but is dispensable for replication in fibroblasts and a renal artery organ-culture system.

Authors:  Detlef Michel; Irena Milotić; Markus Wagner; Bianca Vaida; Jens Holl; Ramona Ansorge; Thomas Mertens
Journal:  J Gen Virol       Date:  2005-02       Impact factor: 3.891

5.  Constitutive signaling of the human cytomegalovirus-encoded chemokine receptor US28.

Authors:  P Casarosa; R A Bakker; D Verzijl; M Navis; H Timmerman; R Leurs; M J Smit
Journal:  J Biol Chem       Date:  2001-01-12       Impact factor: 5.157

6.  RANTES binding and down-regulation by a novel human herpesvirus-6 beta chemokine receptor.

Authors:  R S Milne; C Mattick; L Nicholson; P Devaraj; A Alcami; U A Gompels
Journal:  J Immunol       Date:  2000-03-01       Impact factor: 5.422

7.  Rat cytomegalovirus-accelerated transplant vascular sclerosis is reduced with mutation of the chemokine-receptor R33.

Authors:  Daniel N Streblow; Craig N Kreklywich; Patricia Smith; Jordana L Soule; Christine Meyer; Michael Yin; Patrick Beisser; Cornelis Vink; Jay A Nelson; Susan L Orloff
Journal:  Am J Transplant       Date:  2005-03       Impact factor: 8.086

8.  Phenotypic and genetic polymorphisms among human herpesvirus-6 isolates from North American infants.

Authors:  S Dewhurst; B Chandran; K McIntyre; K Schnabel; C B Hall
Journal:  Virology       Date:  1992-09       Impact factor: 3.616

9.  Short interfering RNA-mediated inhibition of herpes simplex virus type 1 gene expression and function during infection of human keratinocytes.

Authors:  Prakash K Bhuyan; Katalin Karikò; John Capodici; John Lubinski; Lauren M Hook; Harvey M Friedman; Drew Weissman
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

10.  Primary human herpesvirus 6 infection in young children.

Authors:  P Pruksananonda; C B Hall; R A Insel; K McIntyre; P E Pellett; C E Long; K C Schnabel; P H Pincus; F R Stamey; T R Dambaugh
Journal:  N Engl J Med       Date:  1992-05-28       Impact factor: 91.245

View more
  22 in total

Review 1.  Chemokines encoded by herpesviruses.

Authors:  Sergio M Pontejo; Philip M Murphy
Journal:  J Leukoc Biol       Date:  2017-08-28       Impact factor: 4.962

2.  Human herpesvirus 6A infection and immunopathogenesis in humanized Rag2⁻/⁻ γc⁻/⁻ mice.

Authors:  Anne Tanner; Stephanie A Carlson; Masatoshi Nukui; Eain A Murphy; Bradford K Berges
Journal:  J Virol       Date:  2013-09-04       Impact factor: 5.103

3.  The chemokine receptor homologue encoded by US27 of human cytomegalovirus is heavily glycosylated and is present in infected human foreskin fibroblasts and enveloped virus particles.

Authors:  Barry J Margulies; Wade Gibson
Journal:  Virus Res       Date:  2006-09-08       Impact factor: 3.303

4.  Impact of human herpes virus 6 in liver transplantation.

Authors:  Raymund R Razonable; Irmeli Lautenschlager
Journal:  World J Hepatol       Date:  2010-09-27

Review 5.  Viral G Protein-Coupled Receptors Encoded by β- and γ-Herpesviruses.

Authors:  Mette M Rosenkilde; Naotaka Tsutsumi; Julius M Knerr; Dagmar F Kildedal; K Christopher Garcia
Journal:  Annu Rev Virol       Date:  2022-06-07       Impact factor: 14.263

Review 6.  Molecular mechanisms deployed by virally encoded G protein-coupled receptors in human diseases.

Authors:  Silvia Montaner; Irina Kufareva; Ruben Abagyan; J Silvio Gutkind
Journal:  Annu Rev Pharmacol Toxicol       Date:  2012-10-22       Impact factor: 13.820

Review 7.  Human herpesvirus 6 infections after liver transplantation.

Authors:  Rima Camille Abdel Massih; Raymund R Razonable
Journal:  World J Gastroenterol       Date:  2009-06-07       Impact factor: 5.742

8.  The associations between psychosocial stress and the frequency of illness, and innate and adaptive immune function in children.

Authors:  Mary T Caserta; Thomas G O'Connor; Peter A Wyman; Hongyue Wang; Jan Moynihan; Wendi Cross; Xin Tu; Xia Jin
Journal:  Brain Behav Immun       Date:  2008-03-04       Impact factor: 7.217

9.  Immunomodulation and immunosuppression by human herpesvirus 6A and 6B.

Authors:  Lorenzo Dagna; Joshua C Pritchett; Paolo Lusso
Journal:  Future Virol       Date:  2013-03       Impact factor: 1.831

Review 10.  International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors.

Authors:  Francoise Bachelerie; Adit Ben-Baruch; Amanda M Burkhardt; Christophe Combadiere; Joshua M Farber; Gerard J Graham; Richard Horuk; Alexander Hovard Sparre-Ulrich; Massimo Locati; Andrew D Luster; Alberto Mantovani; Kouji Matsushima; Philip M Murphy; Robert Nibbs; Hisayuki Nomiyama; Christine A Power; Amanda E I Proudfoot; Mette M Rosenkilde; Antal Rot; Silvano Sozzani; Marcus Thelen; Osamu Yoshie; Albert Zlotnik
Journal:  Pharmacol Rev       Date:  2013-11-11       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.